← Leaderboards
Changchun Liu
University Of Pennsylvania
$9,548,078
Attributed
$9,843,245
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,843,245 · 9
By mechanism
R01$3,217,519 · 3
U01$2,114,061 · 1
R33$1,629,530 · 1
R61$1,395,095 · 1
R21$845,250 · 2
K25$641,790 · 1
Top collaborators
- Haim H Bau2 shared
- Robert M Greenberg2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Surbhi Grover$3,028,000
- Stephen M Hahn$5,432,347
- Michael J Crawford$816,069
- John Barton Jemmott$37,918,998
- Haim H Bau$5,335,016
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingCostDetectionTrainingInstrumentInnovationTechnologyClinical ApplicationDevicesPoint-Of-Care DiagnosticsPoint Of CarePerformanceReactionSensitivity And SpecificityLaboratoriesResourcesNucleic AcidsCellular PhoneHuman ResourcesDesignMicrofluidic MicrochipsBasePortabilityEquipment
Grant awards (31)
HIV Viral Load Testing Using CRISPR Cascade Signal Amplification$647,533
R01 · FY2025 · AI · contact PI
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care$473,761
U01 · FY2025 · CA · contact PI
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care$66,400
U01 · FY2025 · CA · contact PI
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection$799,475
R33 · FY2024 · AI · contact PI
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care$505,996
U01 · FY2024 · CA · contact PI
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection$830,055
R33 · FY2023 · AI · contact PI
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care$520,639
U01 · FY2023 · CA · contact PI
Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care$547,265
U01 · FY2022 · CA · contact PI
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection$459,781
R61 · FY2022 · AI · contact PI
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection$481,269
R61 · FY2021 · AI · contact PI
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in China$150,036
R01 · FY2021 · CA · contact PI
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA Detection$454,045
R61 · FY2020 · AI · contact PI
A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification$368,466
R01 · FY2020 · EB · contact PI
A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification$331,006
R01 · FY2020 · EB · contact PI
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in China$153,263
R01 · FY2020 · CA · contact PI
A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification$383,282
R01 · FY2019 · EB · contact PI
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in China$156,163
R01 · FY2019 · CA · contact PI
A Reaction-Diffusion-Based Approach for Nucleic Acid Quantification$235,691
R01 · FY2018 · EB · contact PI
Smart Cup: A Mobile Molecular Detection Device for Rapid Diagnosis of Hand Foot and Mouth Disease in China$201,250
R21 · FY2018 · TW · contact PI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings$201,250
R21 · FY2018 · AI
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in China$151,997
R01 · FY2018 · CA · contact PI
A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification$125,534
R01 · FY2018 · EB · contact PI
A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification$354,551
R01 · FY2017 · EB · contact PI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings$241,500
R21 · FY2017 · AI
Smart Cup: A Mobile Molecular Detection Device for Rapid Diagnosis of Hand Foot and Mouth Disease in China$201,250
R21 · FY2017 · TW · contact PI
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in China$159,997
R01 · FY2017 · CA · contact PI
Fully-Integrated, Non-Instrumented Device for Molecular Diagnostics$128,358
K25 · FY2016 · AI · contact PI
Fully-Integrated, Non-Instrumented Device for Molecular Diagnostics$128,358
K25 · FY2015 · AI · contact PI
Fully-Integrated, Non-Instrumented Device for Molecular Diagnostics$128,358
K25 · FY2014 · AI · contact PI
Fully-Integrated, Non-Instrumented Device for Molecular Diagnostics$128,358
K25 · FY2013 · AI · contact PI
Fully-Integrated, Non-Instrumented Device for Molecular Diagnostics$128,358
K25 · FY2012 · AI · contact PI